Page last updated: 2024-09-04

tipifarnib and ATLL

tipifarnib has been researched along with ATLL in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eckhardt, SG; Landau, HJ; Lockerbie, RO; Medeiros, BC; Morrow, M; Pitts, T	1

Other Studies

1 other study(ies) available for tipifarnib and ATLL

Article	Year
The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines. Leukemia, 2007, Volume: 21, Issue:4 Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Line, Tumor; Clone Cells; Farnesyltranstransferase; Humans; Leukemia-Lymphoma, Adult T-Cell; Quinolones; Verapamil	2007

Article

Year

The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines.

Leukemia, 2007, Volume: 21, Issue:4

Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Line, Tumor; Clone Cells; Farnesyltranstransferase; Humans; Leukemia-Lymphoma, Adult T-Cell; Quinolones; Verapamil

2007